trending Market Intelligence /marketintelligence/en/news-insights/trending/mw7A5Yuv68Etj3nA7iOfOA2 content esgSubNav
In This List

Biotricity's remote heart disease monitoring device secures US FDA clearance

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Biotricity's remote heart disease monitoring device secures US FDA clearance

The U.S. Food and Drug Administration granted 510(k) clearance to Biotricity Inc.'s Bioflux device.

Bioflux consists of a proprietary mobile electrocardiography or ECG monitoring device and an ECG viewer software package that enables physicians to remotely monitor and diagnose patients with cardiovascular coronary heart disease.